Particle.news

China's Robot Makers Pivot From Bodies to Brains

A record H1 2026 funding surge pushed firms to build embodied AI for real‑world tasks, but advanced chip shortages, tighter capital, export curbs now constrain near‑term scaling.

X Square humanoid robots demonstrate home work a the company's booth during the 2026 World Robot Conference, in Beijing, China August 19, 2026. REUTERS/Tingshu Wang/File Photo
A sign of ACE Robotics is pictured at the company's booth during the 2026 World Robot Conference, in Beijing, China August 21, 2026. REUTERS/Tingshu Wang/File Photo
A DexForce humanoid robot demonstrates grabbing a bag of peanuts from a shelf at the Robot Valley Exhibition Hall during a government‑organised media trip in Shenzhen, Guangdong province, China, April 16, 2026.  REUTERS/Go Nakamura/File Photo
A humanoid robot by Unitree Robotics competes during a Wushu contest at the 2026 World Humanoid Robot Games at the National Speed Skating Oval in Beijing, China August 26, 2026. REUTERS/Tingshu Wang/File Photo

Overview

  • Chinese embodied‑AI companies raised about 93.5 billion yuan in the first half of 2026, a fivefold jump from a year earlier that shifted investor focus from hardware to robot 'brains'.
  • Embodied AI means software that lets machines perceive, learn and adapt to physical tasks rather than relying on task‑by‑task programming.
  • Startups are collecting physical‑interaction data by hiring people to demonstrate tasks, using wearable sensors, recording human‑guided robot hours and building simulated environments.
  • Select pilots show promise: Spirit AI reports wire‑insertion success above 99% at battery maker CATL and Robbyant runs order handling in Shanghai pharmacies, yet companies say reliable, generalist performance remains a longer road.
  • Firms are coping with U.S. export controls on advanced Nvidia chips and a cooler IPO market by improving model efficiency, increasing synthetic simulation work and seeking domestic chip alternatives, a shift that will shape competition with U.S. labs.